The femoral nerve runs along the anterior medial thigh
A recent phase 2 trial investigated the triple biased GLP-1/GIP/GCC receptors agonist retatrutide (LY3437943) in 338 patients with a mean age of 48 years and BMI of 37.3 kg/m 2 without diabetes (prediabetes in 36% participants) showing BW and WC reduction ranging from 8.7% to 24.2% and 6.5 cm to 19.6 cm in the 1 mg and 12 mg dose groups, respectively, at 48 weeks 41
It is present in human plasma, saliva, and urine, and it plays a role in various biological processes, including wound healing, immune function, and tissue remodeling
Gastrointestinal Health: Due to its origin, this product is thought to have protective effects on the gut lining and may help treat conditions such as inflammatory bowel disease (IBD), ulcers, and other gastrointestinal issues